E-LIB Suche - Ergebnisse für: Inagaki, Akihito

1

Therapeutic activity of retroviral replicating vector-media..:

Niwa, Hiroki ; Nakamura, Toru ; Kushiya, Hiroki...
Cancer Gene Therapy. , 2024

Link: https://doi.org/10.1038/..

2

IMMU-09. DISSECTING THE INTERPLAY BETWEEN THE ENDOGENOUS IM..:

Hoare, Owen ; Jung, Jangham ; Inagaki, Akihito...
Neuro-Oncology. 25 (2023) Supplement_1 - p. i51-i51 , 2023

Link: https://doi.org/10.1093/..

3

Retroviral Replicating Vector Toca 511 (Vocimagene Amiretro..:

Kushiya, Hiroki ; Hiraoka, Kei ; Suzuki, Tomohiro...
Cancers. 14 (2022) 23 - p. 5820 , 2022

Link: https://doi.org/10.3390/..

4

EXTH-33. RETROVIRAL REPLICATING VECTORS PSEUDOTYPED WITH GI..:

Inagaki, Akihito ; Collins, Sara ; Freedman, Alicia...
Neuro-Oncology. 23 (2021) Supplement_6 - p. vi170-vi170 , 2021

Link: https://doi.org/10.1093/..

5

EXTH-65. INSERTION OF MICRORNA TARGET SEQUENCES INTO RETROV..:

Collins, Sara ; Inagaki, Akihito ; Barcova, Maria...
Neuro-Oncology. 23 (2021) Supplement_6 - p. vi178-vi178 , 2021

Link: https://doi.org/10.1093/..

6

EXTH-44. DEVELOPMENT OF RETROVIRAL REPLICATING VECTORS ENCO..:

Collins, Sara ; Inagaki, Akihito ; Tai, Chien-Kuo...
Neuro-Oncology. 22 (2020) Supplement_2 - p. ii96-ii96 , 2020

Link: https://doi.org/10.1093/..

7

THER-06. THERAPEUTIC EFFICACY OF RRV-MEDIATED PRODRUG ACTIV..:

Richardson, Angela ; Collins, Sara ; Inagaki, Akihito...
Neuro-Oncology. 22 (2020) Supplement_3 - p. iii472-iii472 , 2020

Link: https://doi.org/10.1093/..

8

STEM-24. THERAPEUTIC APPROACH OF STEM CELL CARRYING RETROVI..:

Inagaki, Akihito ; Takahashi, Masamichi ; Kamijima, Shuichi...
Neuro-Oncology. 21 (2019) Supplement_6 - p. vi238-vi239 , 2019

Link: https://doi.org/10.1093/..

9

Therapeutic activity of retroviral replicating vector-media..:

Inoko, Kazuho ; Hiraoka, Kei ; Inagaki, Akihito...
Cancer Gene Therapy. 25 (2018) 7-8 - p. 184-195 , 2018

Link: https://doi.org/10.1038/..

10

Retroviral replicating vector–mediated gene therapy achieve..:

Hiraoka, Kei ; Inagaki, Akihito ; Kato, Yuki...
Neuro-Oncology. 19 (2017) 7 - p. 918-929 , 2017

Link: https://doi.org/10.1093/..

11

TMOD-15. TOCA 511 & TOCA FC: PRE-CLINICAL PROOF OF CONCEPT ..:

Inagaki, Akihito ; Richardson, Angela M ; Collins, Sara A...
Neuro-Oncology. 19 (2017) suppl_6 - p. vi257-vi257 , 2017

Link: https://doi.org/10.1093/..

12

PDTM-19. TOCA 511 & TOCA FC: PRE-CLINICAL PROOF OF CONCEPT ..:

Richardson, Angela M ; Collins, Sara A ; Inagaki, Akihito...
Neuro-Oncology. 19 (2017) suppl_6 - p. vi193-vi193 , 2017

Link: https://doi.org/10.1093/..

13

Toca 511 gene transfer and treatment with the prodrug, 5-fl..:

Mitchell, Leah A. ; Lopez Espinoza, Fernando ; Mendoza, Daniel...
Neuro-Oncology. 19 (2017) 7 - p. 930-939 , 2017

Link: https://doi.org/10.1093/..

14

Resistance to cytotoxicity and sustained release of interle..:

Kozlowska, Anna K. ; Tseng, Han-Ching ; Kaur, Kawaljit...
Cancer Immunology, Immunotherapy. 65 (2016) 9 - p. 1085-1097 , 2016

Link: https://doi.org/10.1007/..

15

673. Therapeutic Efficacy of Retroviral Replicating Vector ..:

Inoko, Kazuho ; Hiraoka, Kei ; Inagaki, Akihito...
Molecular Therapy. 24 (2016) - p. S266 , 2016

Link: https://doi.org/10.1016/..